A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination
Overview
Authors
Affiliations
Objective: To estimate the cost of delivering a hepatitis C virus care coordination program at 2 New York City health care provider organizations and describe a potential payment model for these currently nonreimbursed services.
Design: An economic evaluation of a hepatitis C care coordination program was conducted using micro-costing methods compared with macro-costing methods. A potential payment model was calculated for 3 phases: enrollment to treatment initiation, treatment initiation to treatment completion, and a bonus payment for laboratory evidence of successful treatment outcome (sustained viral response).
Setting: Two New York City health care provider organizations.
Participants: Care coordinators and peer educators delivering care coordination services were interviewed about time spent on service provision. De-identified individual-level data on study participant utilization of services were also used.
Intervention: Project INSPIRE is an innovative hepatitis C care coordination program developed by the New York City Department of Health and Mental Hygiene.
Main Outcome Measures: Average cost per participant per episode of care for 2 provider organizations and a proposed payment model.
Results: The average cost per participant at 1 provider organization was $787 ($522 nonoverhead cost, $264 overhead) per episode of care (5.6 months) and $656 ($429 nonoverhead cost, $227 overhead, 5.7 months) at the other one. The first organization had a lower macro-costing estimate ($561 vs $787) whereas the other one had a higher macro-costing estimate ($775 vs $656). In the 3-phased payment model, phase 1 reimbursement would vary between the provider organizations from approximately $280 to $400, but reimbursement for both organizations would be approximately $220 for phase 2 and approximately $185 for phase 3.
Conclusions: The cost of this 5.6-month care coordination intervention was less than $800 including overhead or less than $95 per month. A 3-phase payment model is proposed and requires further evaluation for implementation feasibility. Project INSPIRE's HCV care coordination program provides good value for a cost of less than $95 per participant per month. The payment model provides an incentive for successful cure of hepatitis C with a bonus payment; using the bonus payment to support HCV tele-mentoring expands HCV treatment capacity and empowers more primary care providers to treat their own patients with HCV.
Kapadia S, Eckhardt B, Leff J, Fong C, Mateu-Gelabert P, Marks K Drug Alcohol Depend Rep. 2023; 5.
PMID: 36644226 PMC: 9836210. DOI: 10.1016/j.dadr.2022.100109.
Closing the hepatitis C treatment gap: United States strategies to improve retention in care.
Jones A, Briones C, Tran T, Moreno-Walton L, Kissinger P J Viral Hepat. 2022; 29(8):588-595.
PMID: 35545901 PMC: 9276641. DOI: 10.1111/jvh.13685.
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs.
Gutkind S, Starbird L, Murphy S, Teixeira P, Gooden L, Matheson T Drug Alcohol Depend. 2022; 232:109265.
PMID: 35042101 PMC: 9238179. DOI: 10.1016/j.drugalcdep.2022.109265.
Wyatt B, Perumalswami P, Mageras A, Miller M, Harty A, Ma N Hepatology. 2021; 74(6):2974-2987.
PMID: 34333777 PMC: 9299620. DOI: 10.1002/hep.32086.
Innovations in Hepatitis C Screening and Treatment.
Patel A, Bui A, Prohl E, Bhattacharya D, Wang S, Branch A Hepatol Commun. 2021; 5(3):371-386.
PMID: 33681673 PMC: 7917266. DOI: 10.1002/hep4.1646.